The innovation paradox: pharmaceutical marketing exclusivity and incentives for drug development

ConclusionsIf the length of the pre ‐market process correlates with particular drug types, disease targets, or studied outcomes, we may be offering an inadequate incentive in entire areas of medicine where we have a critical need for new treatments.
Source: Journal of Pharmaceutical Health Services Research - Category: Drugs & Pharmacology Authors: Tags: Research Paper Source Type: research